Anand A, Thakur K, Gupta PK ALS and oxidative stress: the neurovascular scenario. Oxid Med Cell Longev. 2013;2013:635831. doi: 10.1155/2013/635831. Epub 2013 Dec 3. Review.
Beal MF Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol. 1992 Feb;31(2):119-30. Review.
Carilho R, de Carvalho M, Swash M, Pinto S, Pinto A, Costa J Vascular endothelial growth factor and amyotrophic lateral sclerosis: the interplay with exercise and noninvasive ventilation. Muscle Nerve. 2014 Apr;49(4):545-50. doi: 10.1002/mus.23955.
Centre for Clinical Practice at NICE (UK) Motor Neurone Disease: The Use of Non-Invasive Ventilation in the Management of Motor Neurone Disease [Internet]. London: National Institute for Health and Clinical Excellence (UK); 2010 Jul. Available from http://www.ncbi.nlm.nih.gov/books/NBK65383/
Chetta A, Aiello M, Tzani P, Olivieri D Assessment and monitoring of ventilatory function and cough efficacy in patients with amyotrophic lateral sclerosis. Monaldi Arch Chest Dis. 2007 Mar;67(1):43-52. Review.
Dal Bello-Haas V, Florence JM Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2013 May 31;(5):CD005229. doi: 10.1002/14651858.CD005229.pub3. Review.
Hill DW, Rowell AL Significance of time to exhaustion during exercise at the velocity associated with VO2max. Eur J Appl Physiol Occup Physiol. 1996;72(4):383-6.
Paganoni S, Cudkowicz M, Berry JD Outcome measures in amyotrophic lateral sclerosis clinical trials. Clin Investig (Lond). 2014;4(7):605-618.
Pinto A, de Carvalho M, Evangelista T, Lopes A, Sales-Luís L Nocturnal pulse oximetry: a new approach to establish the appropriate time for non-invasive ventilation in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Apr;4(1):31-5.
Pinto S, Swash M, de Carvalho M Respiratory exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012 Jan;13(1):33-43. doi: 10.3109/17482968.2011.626052.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.